论文信息 - Safety and immunogenicity clinical trial of an inactivated SARS-CoV-2 vaccine, BBV152 (a phase 2, double-blind, randomised controlled trial) and the persistence of immune responses from a phase 1 follow-up report - 字舞流文

Safety and immunogenicity clinical trial of an inactivated SARS-CoV-2 vaccine, BBV152 (a phase 2, double-blind, randomised controlled trial) and the persistence of immune responses from a phase 1 follow-up report

K. Ella | S. Panda | G. Sapkal | P. Yadav | P. Abraham | N. Gupta | D. Das | J. Kushwaha | R. Ella | K. M. Vadrevu | H. Jogdand | S. Prasad | S. Reddy | V. Sarangi | B. Ganneru | P. Reddy | S. Verma | C. Singh | S. Redkar | C. S. Gillurkar | S. Mohapatra | B. Bhargava | S. Rai | U. Praturi | A. Bhate | D. Raju